Efor news
12/12/2022
Efor X UTBM Partnership – Together for Telethon
Last December 1st, the Efor and UTBM Junior teams decided to join forces and energy to support the 2022 Telethon.The event include
30/11/2022
DM/DMDIV: Analysis and trend reports during post-marketing surveillance
The Medical Devices Regulations (MDR) 2017/745 and the In Vitro Diagnostic Medical Devices (IVDR) Regulation 2017/746 require the
10/11/2022
Medical and scientific writing
Medical and scientific writing encompasses a range of writing activities in the areas of medicine and science, whether they focus
15/09/2022
AI for the detection of diseases – Image analysis
In recent years, artificial intelligence has played a prominent role in the area of health.Its booming use has to fulfil various t
21/03/2022
Focus on the propensity score
When you are implementing some of the studies managed by Soladis, you may need to calculate a “propensity score”.What
Join our team
Consult our offers
6/01/2022
Why is it important to precisely calculate sample sizes before carrying out studies?
Whether in clinical or industrial studies, numerous standards are emerging to justify sample sizes.This is the case, for example,
16/11/2021
Post-Market Surveillance (PMS), Post-Market Clinical Follow-up (PMCF/PMPF) and PMCF/PMPF Studies
Post-Market SurveillanceFor any MD (including IVDMDs) placed on the market, made available on the market or put into service, manu
12/07/2021
Clean up day : together to clean
As part of the Quality of Life at Work week and the inter-company challenge that our teams participated in last June, we decided t
24/06/2021
Inter- company Connected challenge – Quality of life at work week
Together we are stronger and we go further...
12/04/2021
Evimeria – The Health and Well-being Platform by Efor Group
Evimeria is the innovative health solution developed by the Soladis by Efor teams. Its purpose is to accompany users on a daily ba
4/02/2020
New trends in medical journals: limited use of p-values in favour of estimated indicators and confidence intervals
Why is the p-value, once so widely used, now being called into question?
